These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4024237)

  • 41. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-Dob implicated as the cause of a delayed hemolytic transfusion reaction.
    Moheng MC; McCarthy P; Pierce SR
    Transfusion; 1985; 25(1):44-6. PubMed ID: 3969700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-Jk
    Kay B; Poisson JL; Tuma CW; Shulman IA
    Transfusion; 2016 Dec; 56(12):2973-2979. PubMed ID: 27596036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinically significant allo-anti-I in an I-negative patient with massive hemorrhage.
    Chaplin H; Hunter VL; Malecek AC; Kilzer P; Rosche ME
    Transfusion; 1986; 26(1):57-61. PubMed ID: 3946005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-Cra: family study and survival of chromium-labeled incompatible red cells in a Spanish-American patient.
    Smith KJ; Coonce LS; South SF; Troup GM
    Transfusion; 1983; 23(2):167-9. PubMed ID: 6836696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
    Fasano RM; Chou ST
    Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute Hemolytic Transfusion Reaction Caused by a Red Cell Antibody That Was Missed by Pretransfusion Testing Using Tube Method.
    Shmookler A; Hamad D; Scrape S; Chen J
    Lab Med; 2017 Aug; 48(3):258-261. PubMed ID: 28934518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The sickle cell hemolytic transfusion reaction syndrome.
    Petz LD; Calhoun L; Shulman IA; Johnson C; Herron RM
    Transfusion; 1997 Apr; 37(4):382-92. PubMed ID: 9111275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new low ionic strength test for assessment of pretransfusion compatibility. Studies in vitro and in vivo.
    Szymanski IO; Gandhi JG
    Am J Clin Pathol; 1983 Jul; 80(1):37-42. PubMed ID: 6858963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo red cell destruction by anti-Lu6.
    Issitt PD; Valinsky JE; Marsh WL; DiNapoli J; Gutgsell NS
    Transfusion; 1990; 30(3):258-60. PubMed ID: 2316000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemolytic transfusion reactions in a dog with an alloantibody to a common antigen.
    Callan MB; Jones LT; Giger U
    J Vet Intern Med; 1995; 9(4):277-9. PubMed ID: 8523326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Some observations on the Inb antigen and evidence that anti-Inb causes accelerated destruction of radiolabeled red cells.
    Ferguson DJ; Gaal HD
    Transfusion; 1988; 28(5):479-82. PubMed ID: 3420678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoimmune hemolytic anemia due to auto anti-N in a patient with sepsis.
    Singh L; Malhotra S; Kaur G; Basu S; Kaur R
    Transfus Apher Sci; 2012 Dec; 47(3):269-70. PubMed ID: 22985536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
    Shirey RS; Boyd JS; Parwani AV; Tanz WS; Ness PM; King KE
    Transfusion; 2002 Nov; 42(11):1435-41. PubMed ID: 12421216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A monoclonal antibody directed against the homologous N-terminal domain of glycophorin A and B.
    Edelman L; Blanchard D; Rouger P; Doinel C; Cartron JP; Salmon C; Reviron J
    Exp Clin Immunogenet; 1984; 1(3):129-39. PubMed ID: 6401002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.
    Ambruso DR; Githens JH; Alcorn R; Dixon DJ; Brown LJ; Vaughn WM; Hays T
    Transfusion; 1987; 27(1):94-8. PubMed ID: 3810834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
    Irani MS; Karafin MS; Ernster L
    J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.